Drug General Information
Drug ID
D0PT2M
Drug Name
EGFRvIII-CARs
Drug Type
CAR T Cell Therapy
Indication Recurrent glioblastoma [ICD-11: 2A00.00; ICD-10: C71] Phase 1 [1]
Company
Gary Archer Ph.D.
Target and Pathway
Target(s) Epidermal growth factor receptor variant III (EGFR vIII) Target Info CAR-T-Cell-Therapy [1]
References
REF 1 ClinicalTrials.gov (NCT03283631) Intracerebral EGFR-vIII CAR-T Cells for Recurrent GBM

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Wang and Dr. Li.